je.st
news
Merck Announces Second-Quarter 2013 Financial Results
2013-07-30 13:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. 2013 Second-Quarter Non-GAAP EPS of $0.84, Excluding Certain Items; GAAP EPS of $0.30 Worldwide Sales were $11.0 Billion, a Decrease of 11 Percent Reflecting the Unfavorable Impact of Patent Expiries and a 3 Percent Negative Impact from Foreign Exchange Partially Offset by Global Performance of Human Health Products Growth in Key Franchises Including Vaccines, Diabetes and Immunology Continued Return of Cash to Shareholders, Including $5 Billion Accelerated Share Repurchase Announced in May Reaffirmed Full-Year Non-GAAP EPS Target of $3.45 to $3.55, Excluding Certain Items; Revised GAAP EPS Range to $1.84 to $2.05 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2013. $ in millions, except EPS amounts SecondQuarter2013 SecondQuarter2012 Language: English Contact: Merck & Co., Inc.Media Contacts:Kelley Dougherty, 908-423-4291Steven Cragle, 908-423-3461orInvestor Contacts:Carol Ferguson, 908-423-4465Joe Romanelli, 908-423-5185 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
financial
announces
merck
Category:Biotechnology and Pharmaceuticals